Catheter-directed therapy with the FlowTriever system for intermediate-high and high-risk pulmonary embolism: a single-centre experience
In intermediate-high and high-risk pulmonary embolism patients with ST treatment failure or a contraindication for ST, the FlowTriever thrombosuction system seems to be a minimally invasive alternative treatment modality with low complication rates.
Authors
- Tim P. van de Hoef (ORCID: https://orcid.org/0000-0003-0682-0619)
- Pim van der Harst (ORCID: https://orcid.org/0000-0002-2713-686X)
- Mathilde Nijkeuter (ORCID: https://orcid.org/0000-0003-1406-0699)
- Adriaan O. Kraaijeveld (ORCID: https://orcid.org/0000-0001-5136-5606)
- T. Liu
- Einar A. Hart (ORCID: https://orcid.org/0000-0003-4905-036X)
- Dieuwertje Ruigrok (ORCID: https://orcid.org/0000-0002-8868-6857)
- Paul Eenhoorn
- Michiel Voskuil (ORCID: https://orcid.org/0000-0003-1789-8462)
- Joris van der Heijden (ORCID: https://orcid.org/0000-0002-1730-3521)
- Michael G. Dickinson (ORCID: https://orcid.org/0000-0003-1980-1919)
- J.W. Balder
Institutions
- University Medical Center Utrecht (NL)
Publication Details
- Journal
- Netherlands Heart Journal
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1007/s12471-024-01916-1
- Citations
- 2
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.10